Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

HealthOn vs Midi Health

HealthOn
Graded #343

Higher grade

vs+3
Midi Health
Graded #413

Lower grade

The verdict

HealthOn takes it — 59.4/100 to 56.4/100.

HealthOn grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. HealthOn offers compounded semaglutide and tirzepatide starting at $155/month.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHealthOn +2
47
45
Dose & formulationHealthOn +24
64
40
Clinical oversightHealthOn +1
79
78
Labs & monitoringEven
52
52
FulfillmentMidi Health +16
62
78
Contract termsMidi Health +8
47
55
HealthOn · left barMidi Health · right bar

The numbers

MetricHealthOnMidi Health
WeighScore59.4/10056.4/100
GradeCC
Scorecard rank#343#413
Semaglutide$189/mo (starting dose, 12-month plan, compounded)Not disclosed
Tirzepatide$290/mo (starting dose, 12-month plan, compounded)Not disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
HealthOn

Graded #343 · C

Strengths

  • Both compounded semaglutide and tirzepatide available
  • Weight-loss pricing starts at $189/mo for compounded semaglutide

Where it loses points

  • No visible LegitScript certification or PCAB accreditation
  • State availability not publicly disclosed
  • Lowest advertised prices require a 12-month plan commitment
Midi Health

Graded #413 · C

Strengths

  • Available in all 50 states
  • Accepts commercial insurance — a differentiator vs cash-pay-only GLP-1 telehealth
  • Menopause + metabolic-health focus suits women where GLP-1 efficacy and weight regulation overlap most
  • Transparent self-pay visit fees ($250 initial, $150 follow-up); GLP-1 can also be billed through commercial insurance (copay + deductible)

Where it loses points

  • Does not accept Medicare, Medicaid, or Medi-Cal
  • GLP-1 is prescribed at clinician discretion within a menopause plan, not guaranteed at intake
  • Menopause-focused — not the right fit for men or younger women whose main goal is weight loss

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard